Endogenous opioid mechanisms are implicated in obesity and weight loss in humans

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 8, 2015, Pages 3193-3201

  Burghardt, Paul R ^a,b   Rothberg, Amy E ^b   Dykhuis, Kate E ^b   Burant, Charles F ^b   Zubieta, Jon Kar ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MU OPIATE RECEPTOR; CARBON; CARFENTANIL; FENTANYL;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEEDING BEHAVIOR; FOLLOW UP; HUMAN; LEAN BODY WEIGHT; LOW CALORY DIET; MALE; MIDDLE AGED; OBESITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BINDING; RECEPTOR UPREGULATION; TERTIARY HEALTH CARE; WEIGHT GAIN; WEIGHT REDUCTION; ANALOGS AND DERIVATIVES; BRAIN; CALORIC RESTRICTION; DIET RESTRICTION; EATING; METABOLISM; NEUROIMAGING; PHYSIOLOGY; PROCEDURES;

ADULT; BRAIN; CALORIC RESTRICTION; CARBON RADIOISOTOPES; CASE-CONTROL STUDIES; EATING; FASTING; FENTANYL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROIMAGING; OBESITY; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, OPIOID, MU; WEIGHT LOSS;

EID: 84939158453     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-1783     Document Type: Article

References (40)

1. Friedman J. A war on obesity, not the obese. Science (New York, NY). 2003;299:856-858.
2. Larsen J, van Strien T, Eisinga R, Engels R. Gender differences in the association between alexithymia and emotional eating in obese individuals. J Psychosom Res. 2006;60:237-243.
3. Slochower J, Kaplan S, Mann L. The effects of life stress and weight on mood and eating. Appetite. 1981;2:115-125.
4. Oliver G, Wardle J. Perceived effects of stress on food choice. Physiol Behav. 1999;66:511-515.
5. Zellner D, Loaiza S, Gonzalez Z, et al. Food selection changes under stress. Physiol Behav. 2006;87:789-793.
6. Berthoud H-R. Multiple neural systems controlling food intake and body weight. Neurosci Biobehav Rev. 2002;26:393-428.
7. Kelley AE, Baldo BA, Pratt WE, Will MJ. Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and reward. Physiol Behav. 2005;86:773-795.
8. Gosnell B, Levine A. Reward systems and food intake: role of opioids. Int J Obes. (2005) 2009;33(suppl 2):8.
9. Smith KS, Berridge KC. Opioid limbic circuit for reward: interaction between hedonic hotspots of nucleus accumbens and ventral pallidum. J Neurosci. 2007;27:1594-1605.
10. Rothberg A, McEwen L, Fraser T, Burant C, Herman W. The impact of a managed care obesity intervention on clinical outcomes and costs: a prospective observational study. Obesity (Silver Spring, Md). 2013;\21(11):2157-2162.
11. Scott D, Stohler C, Koeppe R, Zubieta J-K. Time-course of change in [11C]carfentanil and [11C]raclopride binding potential after a nonpharmacological challenge. Synapse (New York, NY). 2007;61:707-714.
12. Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord. 2000;24:38-48.
13. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Personal Soc Psychol. 1988;54:1063-1070.
14. Dannals R, Ravert H, Frost J, Wilson A, Burns H, Wagner H. Radiosynthesis of an opiate receptor binding radiotracer: [11C]carfentanil. Int J Appl Radiat Isotopes. 1985;36:303-306.
15. Jewett D. A simple synthesis of [11C]carfentanil using an extraction disk instead of HPLC. Nucl Med Biol. 2001;28:733-734.
16. Minoshima S, Koeppe R, Mintun M, et al. Automated detection of the intercommissural line for stereotactic localization of functional brain images. J Nucl Med. 1993;34:322-329.
17. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16:834-840.
18. Narendran R, Martinez D. Cocaine abuse and sensitization of striatal dopamine transmission: a critical review of the preclinical and clinical imaging literature. Synapse. 2008;62:851-869.
19. Quelch DR, Katsouri L, Nutt DJ, Parker CA, Tyacke RJ. Imaging endogenous opioid peptide release with [11C]carfentanil and [3H]diprenorphine: influence of agonist-induced internalization. J Cereb Blood Flow Metab. 2014;34:1604-1612.
20. Meyer CR, Boes JL, Kim B, et al. Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations. Med Image Anal. 1997;1:195-206.
21. Karlsson HK, Tuominen L, Tuulari JJ, et al. Obesity Is Associated with decreased μ-opioid but unaltered dopamine D2 receptor availability in the brain. J Neurosci. 2015;35:3959-3965.
22. Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition. 1994;50:7-15.
23. Olson I, Plotzker A, Ezzyat Y. The enigmatic temporal pole: a review of findings on social and emotional processing. Brain. 2007;130:1718-1731.
24. Bencherif B, Guarda A, Colantuoni C, Ravert H, Dannals R, Frost J. Regional μ-opioid receptor binding in insular cortex is decreased in bulimia nervosa and correlates inversely with fasting behavior. J Nucl Med. 2005;46:1349-1351.
25. Zubieta J-K, Ketter T, Bueller J, et al. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Arch Gen Psychiatry. 2003;60:1145-1153.
26. Barfield E, Moser V, Hand A, Grisel J. β-Endorphin modulates the effect of stress on novelty-suppressed feeding. Front Behav Neurosci. 2013;7:19.
27. Umberg E, Pothos E. Neurobiology of aversive states. Physiol Behav. 2011;104:69-75.
28. Wang G, Volkow N, Fowler J, et al. Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology. 1997;16:174-182.
29. Weerts E, Wand G, Kuwabara H, et al. Positron emission tomography imaging of μ- and δ-opioid receptor binding in alcohol-dependent and healthy control subjects. Alcohol Clin Exp Res. 2011;35:2162-2173.
30. Heinz A, Reimold M, Wrase J, et al. Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil. Arch Gen Psychiatry. 2005;62:57-64.
31. Kelley AE, Bakshi VP, Haber SN, Steininger TL, Will MJ, Zhang M. Opioid modulation of taste hedonics within the ventral striatum. Physiol Behav. 2002;76:365-377.
32. Glass M, Billington C, Levine A. Opioids and food intake: distributed functional neural pathways? Neuropeptides. 1999;33:360-368.
33. Gosnell B, Krahn D, Majchrzak M. The effects of morphine on diet selection are dependent upon baseline diet preferences. Pharmacol Biochem Behav. 1990;37:207-212.
34. Glass M, Grace M, Cleary J, Billington C, Levine A. Potency of naloxone's anorectic effect in rats is dependent on diet preference. Am J Physiol. 1996;271:21.
35. Zubieta JK, Smith YR, Bueller JM, et al. Regional μ opioid receptor regulation of sensory and affective dimensions of pain. Science. 2001;293:311-315.
36. Koob G, Le Moal M. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat Neurosci. 2005;8:1442-1444.
37. Walsh Z, Epstein A, Munisamy G, King A. The impact of depressive symptoms on the efficacy of naltrexone in smoking cessation. J Addict Dis. 2008;27:65-72.
38. Kranzler H, Armeli S, Feinn R, Tennen H. Targeted naltrexone treatment moderates the relations between mood and drinking behavior among problem drinkers. J Consult Clin Psychol. 2004;72:317-327.
39. Taut D, Renner B, Baban A. Reappraise the situation but express your emotions: impact of emotion regulation strategies on ad libitum food intake. Front Psychol. 2012;3:359.
40. Oliver G, Wardle J, Gibson E. Stress and food choice: a laboratory study. Psychosom Med. 2000;62:853-865.